These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 13127427)
21. [Methionine and choline in diseases of liver parenchyma]. HOBURG H Dtsch Med J; 1955 Sep; 6(17-18):586-7. PubMed ID: 13261815 [No Abstract] [Full Text] [Related]
23. The use of lipotropic factors in the treatment of liver disease. CAYER D; CORNATZER WE Gastroenterology; 1952 Mar; 20(3):385-402. PubMed ID: 14906636 [No Abstract] [Full Text] [Related]
25. Clinical and nutritional aspects of lipotropic agents; with special reference to their role in the pathogenesis and treatment of fatty cirrhosis of the liver. GABUZDA GJ J Am Med Assoc; 1956 Mar; 160(11):969-75. PubMed ID: 13295052 [No Abstract] [Full Text] [Related]
26. The effect of massive doses of myo-inositol on hepatic phospholipid metabolism. Yagi K; Kotaki A Ann N Y Acad Sci; 1969 Oct; 165(2):710-25. PubMed ID: 4186706 [No Abstract] [Full Text] [Related]
27. LIPOTROPICS as invaluable therapeutic agents. J Iowa State Med Soc; 1952 Feb; 42(2):66-7. PubMed ID: 14908214 [No Abstract] [Full Text] [Related]
28. [Action of lipotropic factors on hepatic steatosis in experimental hypoxia]. VENTURI VM Arch Int Pharmacodyn Ther; 1955 Oct; 103(2-3):238-42. PubMed ID: 13259736 [No Abstract] [Full Text] [Related]
29. [Effect of lipotropic substances upon blood and liver lipoids in experimental fatty liver and in liver cirrhosis in man]. HARTMANN F; LEUSCHNER F Klin Wochenschr; 1950 Aug; 28(29-30):514-5. PubMed ID: 15437871 [No Abstract] [Full Text] [Related]
30. [Hepatic steatosis due to phosphorus; lipotropic action of choline and of combined choline-inositol]. CATOLLA-CAVALCANTI A Minerva Med; 1950 Nov; 41(56):927-31. PubMed ID: 14796495 [No Abstract] [Full Text] [Related]
31. INEFFECTIVENESS OF LIPOTROPIC SUBSTANCES IN POSTIRRADIATION FATTY INFILTRATION OF THE LIVER. SKALKA M Folia Biol (Praha); 1963; 9():319-21. PubMed ID: 14061369 [No Abstract] [Full Text] [Related]
32. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"]. Gheorghescu B; Steflea D; Jovin G; Suseanu I Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192 [No Abstract] [Full Text] [Related]
33. Development of portal fatty liver in rats on corn diets; response to lipotropic agents. SHILS ME; STEWART WB Proc Soc Exp Biol Med; 1954 Feb; 85(2):298-303. PubMed ID: 13155577 [No Abstract] [Full Text] [Related]
34. [Critical evaluation of cholinemethionine therapy in liver diseases]. KIPPING H Dtsch Med J; 1954 Dec; 5(23-24):669-72. PubMed ID: 14352896 [No Abstract] [Full Text] [Related]
35. [RESEARCH RELATIVE TO THE PROBLEM OF LACK OF APPETITE DURING PROLONGED MEDICAL THERAPY]. GUERTLER J Sem Med; 1963 Oct; 123():1359-62. PubMed ID: 14108863 [No Abstract] [Full Text] [Related]
36. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice]. Stuchlik S Med Monatsschr; 1977 Nov; 31(11):524-6. PubMed ID: 927326 [No Abstract] [Full Text] [Related]
37. [Comparative results of therapy in parenchymal liver diseases]. GEISBERGER H Wien Med Wochenschr; 1957 Mar; 107(12):240-2. PubMed ID: 13434140 [No Abstract] [Full Text] [Related]
38. [Therapy with hepsan in practice]. DOLAINSKI O Ther Ggw; 1953 Dec; 92(12):444-6. PubMed ID: 13136093 [No Abstract] [Full Text] [Related]
39. [The action of various lipotropic substances on the steatogenic effects of carbon tetrachloride as a function of time]. BECCARI E; GARESIO T Arch Ital Sci Farmacol; 1956 Jul; 6(3):212-6. PubMed ID: 13382459 [No Abstract] [Full Text] [Related]